Market Tracker

04/26 5:15pm ET

Novavax Inc (NASDAQ:NVAX)

1.62
Delayed Data
As of 4:00pm ET
 -0.02 / -1.22%
Today’s Change
0.73
Today|||52-Week Range
2.75
+30.65%
Year-to-Date

Today’s Trading

Previous close1.64
Today’s open1.64
Day’s range1.60 - 1.68
Volume3,220,577
Average volume (3 months)10,599,538
Market cap$646.0M
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.79%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.02-0.56%
EDGEEdge Therapeutics In...+0.06+5.22%
BTXBioTime Inc+0.05+2.25%
RIGLRigel Pharmaceutical...-0.04-1.08%
Data as of 8:00pm ET, 04/26/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts